As one of the critical targets of DHYZ against AD, ALDH3B2 expression decreased significantly in the brain of 2× Tg-AD mice as compared to the control mice (P < 0.01), which was detected with fluorescence immunoassay and Western blotting (Figures 8E,F). This evidence concerns the gene ALDH3B2 and Alzheimer disease.